RENAISSANCE TECHNOLOGIES LLC

Position in CGC — Canopy Growth Corp

CIK 1037389 NEW YORK, NY

Back to CGC Full portfolio

Position in CGC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$28,975

-$432,462 QoQ

Shares Held

30,500

-43.0% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#51

of 212 holders

Holding Since

Dec 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGC Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. CGC ranks #46 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	1,708,739	$925,846,052
2	NBIX	Neurocrine Biosciences Inc	2,335,897	$393,692,080
3	ALKS	Alkermes plc.	6,460,928	$338,552,627
4	RDY	Dr Reddys Laboratories Ltd	7,347,028	$106,458,435
5	ZTS	Zoetis Inc.	1,403,300	$100,841,138
6	SUPN	Supernus Pharmaceuticals, Inc.	1,478,180	$68,750,151
7	COLL	Collegium Pharmaceutical, Inc	1,366,549	$49,469,073
8	PCRX	Pacira BioSciences, Inc.	1,733,801	$43,986,531

All Filings in CGC

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$28,975	30,500	-43.0%	Shares	Sole	2026-08-13
2024-03-31	$461,437	53,469	-32.6%	Shares	Sole	2024-05-13
2023-12-31	$405,263	79,308	-26.1%	Shares	Sole	2024-02-13
2023-09-30	$83,985	107,261	-90.7%	Shares	Sole	2023-11-14
2021-12-31	$10,070,928	1,153,600	-39.4%	Shares	Sole	2022-02-11
2021-09-30	$26,374,194	1,902,900	+240.4%	Shares	Sole	2021-11-12
2021-06-30	$13,515,193	558,941	+158.2%	Shares	Sole	2021-08-13
2021-03-31	$6,934,495	216,500	+0.0%	Shares	Sole	2021-05-13
2020-12-31	$5,332,096	216,400	—	Shares	Sole	2021-02-10
No filing history on record for this holder in this stock.